Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
10/2012
10/04/2012US20120251447 Radioiodinated tropane derivatives
10/04/2012US20120251446 Peptide Conjugates Comprising Polyhistidine Sequence and Free Cysteine and Their Uses in Imaging
10/04/2012US20120251445 Peptides whose uptake by cells is controllable
10/04/2012US20120251444 Treatment of liver disorders by administration of rap conjugates
10/04/2012US20120251443 Implantable contrast agents and methods
10/04/2012US20120251442 Methods for Treatment of Tumors by Direct Administration of a Radioisotope
10/04/2012US20120251441 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with diseases like cachexia and correction of adverse effects of drugs such as immunosuppression, neutropenia and lymphopenia, comprising the association or combination of a biological response modifier specially selected and other substances with antineoplastic action and/or other treatments
10/04/2012US20120251440 Methods of myocardial perfusion imaging
10/04/2012US20120251439 Antigens Associated with Inflammatory Bowel Disease Including Ulcerative Colitis
10/04/2012CA2831426A1 Methods for increasing efficacy of folr1 cancer therapy
10/04/2012CA2830984A1 Inhibitors of 17.beta.-hsd1, 17.beta.-hsd3 and 17.beta.-hsd10
10/03/2012EP2504035A2 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
10/03/2012CN102712603A Radioiodination method
10/03/2012CN102712575A Homoglutamic acid derivatives
10/03/2012CN102712552A Method for production of F-18 labeled glutamic acid derivatives
10/03/2012CN102711841A Iodine-labeled homoglutamic acid and glutamic acid derivatives
10/03/2012CN102711605A Measuring device and method for analysing test gas by means of infrared absorption spectroscopy
10/03/2012CN102020768B 99mTc coordination compound, preparation method, intermediate and application thereof
10/03/2012CN101891791B Derivate for labeling bile acid and reference compound, preparation method and application thereof
10/03/2012CN101654465B Caobonyl technetium labeled 2-azomycin composition, preparation method and application
10/02/2012US8278042 Compositions and methods for the diagnosis and treatment of tumor
10/02/2012US8277847 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
10/02/2012US8277823 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
10/02/2012US8277777 Compound having affinity for amyloid
10/02/2012US8277776 Compositions for delivery of therapeutics and other materials
10/02/2012US8277775 Boron dipyrromethene difluoro (BODIPY) conjugates
10/02/2012CA2517459C Heterobifunctional polymeric bioconjugates
10/02/2012CA2410906C Ethylenedicysteine (ec)-drug conjugates
09/2012
09/30/2012CA2772767A1 Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling
09/27/2012WO2012126157A1 Annexin v variant, and preparation and use thereof
09/27/2012US20120244074 Labelled integrin binders
09/27/2012US20120244073 Aryloxyanilide imaging agents
09/27/2012US20120244072 Preparation of n-monofluoroalkyl tropanes
09/27/2012US20120244071 Fty720 halogenated derivatives
09/27/2012US20120244070 Fibronectin targeting contrast agent
09/27/2012US20120244069 Human monoclonal antibodies against cd25
09/27/2012US20120244068 Microorganisms for imaging and/or treatment of tumors
09/27/2012US20120244067 Methods for inducing reversible stasis
09/26/2012EP2502938A2 Antibodies and immunoconjugates and uses therefor
09/26/2012EP2502937A2 Anti-CD 79b Antibodies And Immunoconjugates And Methods Of Use
09/26/2012EP2501696A2 Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
09/26/2012EP2501663A2 Method for production of f-18 labeled glutamic acid derivatives
09/26/2012EP2501416A1 Iodine-labeled homoglutamic acid and glutamic acid derivatives
09/26/2012CN102695527A Molecular probe for imaging of pancreatic islet, and use thereof
09/26/2012CN102690345A Human annexin V variant and its expression, preparation method and use
09/26/2012CN102688508A Targeting radioactive micro/nano fluid preparation
09/26/2012CN101861170B Improved radiopharmaceutical composition
09/25/2012US8273704 Use of repeat sequence protein polymers in personal care compositions
09/25/2012US8273328 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
09/25/2012US8273327 Radio-opaque compounds, compositions containing same and methods of their synthesis and use
09/25/2012US8273326 Imaging infection with compounds that bind to thymidine kinase
09/25/2012US8273325 Contrast agents
09/25/2012US8273324 Embolization
09/25/2012CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
09/25/2012CA2526556C Stable radiopharmaceutical compositions and methods for their preparation
09/25/2012CA2512310C Improved linkers for radiopharmaceutical compounds
09/20/2012US20120237446 Compounds for binding and imaging amyloid plaques and their use
09/20/2012US20120237445 Stabilization of radiopharmaceutical compositions using ascorbic acid
09/20/2012US20120237444 Iodine radiolabelling method
09/20/2012US20120237443 Functionalizing implantable devices with a poly (diol citrate) polymer
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012US20120237441 Enhanced b cell cytotoxicity of cdim binding antibody
09/19/2012EP2500338A1 F-labeled azide compound, reagent for 18f-labeling and method for 18f-labeling of alkyne compound using same
09/19/2012EP2500040A1 Improved Gastrin Releasing Peptide Receptor-Binding Compounds
09/19/2012EP2499113A1 Homoglutamic acid derivatives
09/19/2012EP2498826A1 Labelled pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their use in diagnostic methods
09/19/2012CN1607006B Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
09/19/2012CN102686612A Conjugates targeting the CD163 receptor
09/19/2012CN102675500A Method for preparing polymer-supported organotin compound by using organic magneson and application of organotin compound
09/19/2012CN102675329A Positron emission tomography agent and preparation method thereof
09/19/2012CN102671220A Radioactive anion resin microsphere and method for preparing same
09/19/2012CN102671219A Radioactive anion resin microsphere and preparation method (1) thereof
09/19/2012CN102671218A Lyophilized powder kit for preparing 99mTc-GSA and preparation method and application thereof
09/19/2012CN102040631B Preparation method and application of <99m>technetium (Tc) labeled 2-nitroimidazole xanthate complexes
09/18/2012US8268358 Use of simple amino acids to form porous particles
09/18/2012US8268345 Multipurpose hydrogel compositions and products
09/18/2012US8268335 Skin treatment systems
09/18/2012US8268312 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
09/18/2012US8268291 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
09/18/2012CA2533321C Bicyclic peptide imaging agents
09/18/2012CA2522326C Bifunctional tridentate pyrazolyl containing ligands for re, tc and mn tricarbonyl complexes
09/18/2012CA2492855C Myocardial perfusion imaging using a2a receptor agonists
09/18/2012CA2428274C Device for synthesis of radiopharmaceutical products
09/13/2012WO2012122471A2 Compounds and methods of use in ablative radiotherapy
09/13/2012WO2012121610A1 In vivo methods of monitoring biodistribution
09/13/2012WO2012121285A1 Labeling precursor compound, radioactively labeling compound, and processes for producing those compounds
09/13/2012WO2012119937A1 Technetium labelled peptides
09/13/2012US20120232325 Radioactive bone cement
09/13/2012US20120230914 Labeling compound for pet
09/13/2012US20120230913 Protein nanoparticle dispersions
09/13/2012US20120230912 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
09/13/2012US20120230911 Tnf-alpha binding proteins
09/13/2012CA2829217A1 Compounds and methods of use in ablative radiotherapy
09/13/2012CA2828655A1 Technetium labelled peptides
09/12/2012EP2497501A2 Radionuclides for medical use
09/12/2012EP2496270A1 Zirconium-radiolabeled, cysteine engineered antibody conjugates
09/12/2012CN102666576A Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
09/12/2012CN102666567A Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
09/12/2012CN102659946A Anti-alpha v beta 6 antibodies
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 243